Reveal Surgical articles

Summary: In treating brain cancers, neurosurgeons face a critical decision: remove too little tissue and risk fatal recurrences or remove too much and cause profound neurological damage. Presently, they rely on pre-operative surgical navigation technologies, such as MRI, in order to determine the contours of the cancerous tissue to be safely removed. These surgical navigation systems, in conjunction with surgical microscopes, can generally identify the tumor bulk, but fa

A fibre-optic probe can detect errant cancer cells within healthy tissue during brain tumour surgery with close to 100 per cent accuracy and sensitivity, reducing the risk of recurrence and thereby increasing a patient’s survival time, say the Canadian researchers who developed the device.

The hand-held, pen-like instrument, known as a Raman spectroscopy probe, is able to differentiate between cancer cells and healthy cells by measuring the way each reflects las

ODS Medical will undertake within a few weeks the first official clinical trial which will allow it to test its surgical probe, a tool capable of discerning, in real time, cancerous tissue from healthy tissue in brain operated patients.

But before arriving there, she chose to surround herself well.

The company has just signed an agreement with an American medical equipment manufacturer whose identity it cannot reveal.

In addition to looking into the regulatory aspects